Zika Diagnostics, Inc., formerly Watermark Group, Inc., is a development stage company engaged in developing medical diagnostic tools. The Company intends to develop diagnostic tools targeting the zika virus. It holds the license to develop, use, manufacture, market and license polymerase chain reaction (PCR) tests. PCR system is a molecular diagnostic platform used for the molecular testing of organisms and genetic diseases. The Company develops PCR tests for detecting zika virus and other mosquito-borne flaviviruses, which include dengue, yellow fever, West Nile virus, alpha virus chikunguniya, and Japanese encephalitis. It offers multiplex tests for all flaviviruses that exhibit similar symptoms, and differentiates them to diagnose specific infections.
More about the company